bf/NASDAQ:MIST_icon.png

COM:MILESTONEPHARMA

Milestone Pharmaceuticals, Inc.

  • Stock

Last Close

1.79

07/11 21:00

Market Cap

77.39M

Beta: -

Volume Today

1.76M

Avg: -

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of...Show More

competitor of